Secondary analysis of the phase III TOPGEAR trial (574 with resectable gastric cancer; 135 aged ≥70): older adults needed more preoperative dose modifications but had similar grade ≥3 toxicity, surgical outcomes, OS and PFS to younger patients.
Secondary analysisn = 574
Rühle et al. Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial